7561 Share Price Performance
NT$24.50
1.60 (6.99%)
Price NT$24.50
Share PriceNT$24.50
Are Bioray Biotech Co., Ltd's (GTSM:7561) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 20
Bioray Biotech Co., Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7561 Community Narratives
There are no narratives available yet.
Bioray Biotech Co., Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.03
- Gross Margin
- 46.77%
- Net Profit Margin
- 13.26%
- Debt/Equity Ratio
- 0%
Bioray Biotech Co., Ltd Competitors
Snowflake Analysis
About 7561
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Bioray Biotech Co., Ltd engages in the research and development, manufacture, and sale of biological and health supplement products. Its biological products include functional probiotics, medicinal fungi, and immune cell preparations. The company is also involved in the cell testing and storage business. Bioray Biotech Co., Ltd was founded in 1994 is based in Pingtung, Taiwan.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Taiwanese Market Performance
- 7 Days: 3.8%
- 3 Months: 18.7%
- 1 Year: 17.6%
- Year to Date: 17.4%
Over the last 7 days, the market has risen 3.8%, driven by gains of 5.5% in the Information Technology sector. In contrast, the Healthcare sector is lagging, dropping 3.9%. As for the past 12 months, the market is up 18%. Earnings are forecast to grow by 18% annually. Market details ›